Survival in BRAF V600–Mutant Advanced Melanoma Treated with Vemurafenib-Reference-Cited by-同舟云学术

Survival in BRAF V600–Mutant Advanced Melanoma Treated with Vemurafenib

Published:2012-02-23 Issue:8 Volume:366 Page:707-714
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Sosman Jeffrey A.,Kim Kevin B.,Schuchter Lynn,Gonzalez Rene,Pavlick Anna C.,Weber Jeffrey S.,McArthur Grant A.,Hutson Thomas E.,Moschos Stergios J.,Flaherty Keith T.,Hersey Peter,Kefford Richard,Lawrence Donald,Puzanov Igor,Lewis Karl D.,Amaravadi Ravi K.,Chmielowski Bartosz,Lawrence H. Jeffrey,Shyr Yu,Ye Fei,Li Jiang,Nolop Keith B.,Lee Richard J.,Joe Andrew K.,Ribas Antoni

Publisher

Massachusetts Medical Society

Subject

General Medicine

Link

http://www.nejm.org/doi/pdf/10.1056/NEJMoa1112302

Cited by 1874 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exosomal miR-19a derived from melanoma cell promotes the vemurafenib resistance of malignant melanoma through directly targeting LRIG1 to reactivate AKT and MAPK pathway;Pathology - Research and Practice;2024-08

2. Interaction of DisBa01 peptide from Bothrops alternatus venom with BRAF melanoma receptors: Modeling and molecular docking;International Journal of Biological Macromolecules;2024-08

3. An Automated Real-Time PCR Assay versus Next-Generation Sequencing in the Detection of BRAF V600 Mutations in Melanoma Tissue Samples;Diagnostics;2024-07-30

4. Effect of Ibuprofen as an Albumin Binder on Melanoma-Targeting Properties of ¹⁷⁷Lu-Labeled Ibuprofen-Conjugated Alpha-Melanocyte-Stimulating Hormone Peptides;Molecular Pharmaceutics;2024-07-08

5. Advances in Understanding and Management of Erdheim-Chester Disease;Life Sciences;2024-07